Vir Biotechnology Kicks Off Covid-19 Treatment Trial; Shares Rise 6.1%
ChromaDex Pops 28% On Anti-Ageing Supplement Covid-19 Study
Exclusive Pharma Microbiology interview with Maria Jose Lopez Barragan, formerly at FDA
COVID-19 Outbreaks Worsen In NY, NJ & CT As Cuomo Outlines New Plan For Containing 'Hot Spots': Live Updates
White House Acquiesces To FDA's COVID-19 Vaccine Emergency-Approval Guidelines
New research supports sofosbuvir in combination with other antivirals for COVID-19
If COVID-19 Antibody 'Cocktails' Become Popular, Sorrento Stock Could Double, Says Analyst
FDA Outlines Requirements For "Emergency Use Authorization" Of COVID-19 Vaccine Amid Reports Of WH Interference
How the leading coronavirus vaccines work
NYC Schools Close As COVID-19 Makes "Dangerous Comeback" Across US: Live Updates
Race for COVID-19 vaccine hots up as EMA begins review of BioNTech/Pfizer jab
J&J settles 1,000 talc lawsuits for $100m+; report
The 6 Degrees of Separating Coronavirus from President Trump
Gilead vs Pfizer: Which Healthcare Stock Has Stronger Prospects?
Covid-19 roundup: Top analyst: Regeneron EUA likely this week — unless Trump takes a turn for worse; UK says less than half of residents will be vaccinated
Trump’s Treatments: Regeneron’s Antibodies and Gilead’s Remdesivir Explained
Microchip'd? DARPA Biochip To "Save" Us From COVID Can Control Human DNA
Trump treated with experimental antibody cocktail for Covid-19
Trump Has "Low-Grade Fever, Nasal Congestion And A Cough"; Treated With Regeneron Antibody Cocktail: Live Updates
AstraZeneca’s Japanese Covid-19 vaccine trial back up, U.S. still paused
Gene Therapy’s Renaissance
European regulators begin rolling review of AZ’s COVID-19 vaccine
Alone in the spotlight, Pfizer CEO Bourla swears pure intentions in the rush to develop a Covid-19 vaccine. But will the public believe it?
3 "Strong Buy" Healthcare Stocks Under $5 That Could Go Boom
AstraZeneca’s Covid-19 Vaccine Put On Fast Track By EU Regulator
EMA review of AZ’s COVID-19 vaccine imminent; report
Bidding to be the go-to genomics and data partner for drug development, Sophia Genetics raises $100M
Futures Surge After Stimulus Pessimism Turns To Stimulus Optimism
MRNA Stock Price Pushes Higher On News COVID-19 Vaccine Works For Seniors
Automating clinical trials: Why it’s essential for success